Loyal Appoints Blake Scholl to its Board of Directors
Scholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world's first FDA-approved longevity drug Loyal, a biotech company developing the world's first drugs intended to extend the healthy lifespan of dogs, …